ASN also heads the national committee in charge of monitoring the National Plan for Radon Risk Management. The 4th plan was intended to cover the period 2020-2024. The Covid-19 pandemic crisis delayed the completion of the regulatory system and the launch of certain measures. The plan is therefore prolonged for a period of two years. The indicators analysis was published for the first time in 2024 (see chapter 1). Within the context of this plan, ASN has since 2018 been overseeing a WG in charge of coordinating radon risk management communication actions, which meets twice a year. 2.7 The other stakeholders As part of its missions to protect the general public from the health risks of ionising radiation, ASN cooperates closely with other institutional stakeholders with competence for health issues. 2.7.1 The National Agency for the Safety of Medicines and Health Products The National Agency for the Safety of Medicines and Health Products (ANSM) was created on 1 May 2012. The ANSM, a public institution reporting to the Ministry in charge of health, has taken up the functions of the French Health Products Safety Agency (AFSSAPS) alongside other new responsibilities. Its key roles are to offer all patients equitable access to innovation and to guarantee the safety of health products throughout their life cycle, from initial testing through to monitoring after receiving marketing authorisation. The site ansm.sante.fr presents the Agency and its actions. This agreement is currently being renewed. 2.7.2 French National Authority for Health The essential role of French National Authority for Health (HAS), an independent administrative Authority created in 2004, is to maintain an equitable health system and improve the quality of patient care. The site has‑sante.fr presents the Authority and its actions. There has been an ASN-HAS agreement since 2008; it was renewed on 2 March 2021 for a six-year period. An ASN-HAS action plan is appended to this agreement and is regularly updated. 2.7.3 French National Cancer Institute Created in 2004, the French National Cancer Institute (INCa) is primarily responsible for coordinating activities in the fight against cancer. The site e-cancer.fr presents the Institute and its actions. Regular discussions take place between INCa and ASN. 2.8 The safety regulators: an international comparison Table 2 describes the status and activities of the safety regulators. In terms of status, most of these regulatory authorities are Government or independent agencies. With regard to their activities, most of them regulate and oversee the complete spectrum of nuclear activities, including in terms of protection against malicious acts (except for France with regard to malicious acts). TABLE 2 Status and activities of the main civil nuclear safety regulators(*) in 2024 Country / Regulatory Authority Status Activities Administration Govern‑ ment agency Independent agency Safety of civil facilities Radiation protection Security (protection against malicious acts) Transport safety Large nuclear installa‑ tions Outside BNIs Patients Sources Nuclear materials Europe Germany/Bmub + Länder ■ ■ ■ ■ ■ ■ ■ ■ Belgium/AFCN ■ ■ ■ ■ ■ ■ ■ ■ Spain/CSN ■ ■ ■ ■ ■ ■ ■ ■ Finland/STUK ■ ■ ■ ■ ■ ■ ■ ■ France/ASN ■ ■ ■ ■ ■ ■(**) ■ United Kingdom/ONR ■ ■ ■ ■ ■ ■ Sweden/SSM ■ ■ ■ ■ ■ ■ ■ ■ Switzerland/ENSI ■ ■ ■ ■ ■ Other countries Canada/CCSN ■ ■ ■ ■ ■ ■ ■ ■ China/NNSA ■ ■ ■ ■ ■ ■ ■ Korea/NSSC ■ ■ ■ ■ ■ ■ ■ United States/NRC ■ ■ ■ ■ ■ ■ ■ ■(***) India/AERB ■ ■ ■ ■ ■ ■ ■ ■ Japan/NRA ■ ■ ■ ■ ■ ■ ■ ■ Russia/ Rostekhnadzor ■ ■ ■ ■ ■ ■ ■ Ukraine/SNRIU ■ ■ ■ ■ ■ ■ ■ ■ * Schematic and simplified representation of the main areas of competence of the entities (administration, independent agencies within government or independent agencies outside government) responsible for regulating nuclear activities in the world’s nuclear countries. ** Responsibility for source security was given to ASN by the Ordinance of 10 February 2016. This provision came into force on 1 July 2017. *** National transports only. 142 ASN Report on the state of nuclear safety and radiation protection in France in 2024 The principles of nuclear safety and radiation protection and the regulation and oversight stakeholders
RkJQdWJsaXNoZXIy NjQ0NzU=